Infertility associated with polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: First Intervention group (Group A): Subcutaneous injection of 0.2mg Decapeptyl ampoule (GnRH-a) that will be repeated with a half-dose after 12 hr. Intervention 2: Second Intervention
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 38 Years
Inclusion criteria
Inclusion criteria: Aged between 18-38 years old Body mass index below 30 and above 19 kg/m2 Normal uterine cavity Ovulation induction by GnRH antagonist cycle regimen
Exclusion criteria
Exclusion criteria: Repeated implantation failure WHO 1 group Using Percutaneous Epididymal Sperm Aspiration (PESA) or testicular sperm extraction (TESE) History of taking oral contraceptive pills for more than three months before the IVF Endocrinopathies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovarian hyperstimulation syndrome (OHSS). Timepoint: At the end of the study. Method of measurement: Hospital records.;Metaphase II (MII) oocytes. Timepoint: At the end of the study. Method of measurement: Hospital records.;Total Number of oocytes. Timepoint: At the end of the study. Method of measurement: Hospital records.;Number of embryos. Timepoint: At the end of the study. Method of measurement: Hospital records. | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: At the time of embryo transfer. Method of measurement: Vaginal Ultrasound.;Embryos quality. Timepoint: At the end of the study. Method of measurement: Hospital records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mahdiyeh Sadat Portabatabaei
Arash Women 's Hospital
Outcome results
None listed